Markets:

Overview

News

Currencies

International

Treasuries

Bright Minds Biosciences Inc. - common stock (NQ:DRUG)

50.91 -0.75 (-1.46%)

Streaming Delayed Price Updated: 10:00 AM EDT, Sep 29, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Bright Minds Biosciences Inc. - common stock

< Previous 1 2 3 4 5 Next >

Psyched: Steve Cohen's New Biopharma Bet, California Gov. Authorizes Medical Psychedelics & More ↗

October 06, 2023

Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares

Via Benzinga

Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More ↗

October 02, 2023

Depression Relief: Possible Therapy Boost With DMT & SSRIs Small Pharma Clinical Results New findings on safety, tolerability and efficacy from a clinical study assessing the interaction of...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

September 28, 2023

We're checking out the biggest pre-market stock movers worth watching on Friday with a dive into all of the latest market stories!

Via InvestorPlace

Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More ↗

September 26, 2023

Billionaire Steve Cohen Buys 19M Shares Of Cybin Stock For Psychedelics R&D, Blake Mycoskie $100M Pledge

Via Benzinga

Topics Economy

Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More ↗

September 18, 2023

Treating PTSD With MDMA Therapy: New Results From MAPS Clinical Study, FDA Submission Next

Via Benzinga

Psyched: Psilocybin Therapy For Depression, UK Rescheduling, US Policy Reform And More ↗

September 11, 2023

Single Psilocybin Dose 'Significantly' Reduces Major Depression Symptoms, An AI Predictive Model, And UK’s Struggle For Reclassification

Via Benzinga

Topics Artificial Intelligence

Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More ↗

September 05, 2023

Cybin's Acquisition Of Small Pharma Will Elevate DMT Therapeutics For Depression And Anxiety

Via Benzinga

Psyched: Psilocybin For Gambling Addiction, Ex-NHL Player's Retreat, Fellini's LSD Creativity, Surveys, Financing & More ↗

August 28, 2023

Psilocybin Therapy Trials: Gambling Addiction Study, Opioid Pain & Alcohol Addiction Trials

Via Benzinga

Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports ↗

August 21, 2023

Cannabis, Psychedelics Use And Binge Drinking At All-Time High Among Adults, Teens Remain Stable, Fed Study Finds

Via Benzinga

Topics Cannabis Economy

Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More ↗

August 14, 2023

First Ever Professional Practice Guidelines For Psychedelic-Assisted Therapy Published

Via Benzinga

Why Cutera Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Wednesday's Session ↗

August 09, 2023

Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesday. Tango Therapeutics recently posted a narrower quarterly loss.

Via Benzinga

Biotech Market Update: Global Pharmaceuticals Market Expected to Reach $1.5 Trillion by Year’s End

August 09, 2023

EQNX::TICKER_START (NYSE:PTN),(NASDAQ:CRDF),(NASDAQ:BDRX),(NASDAQ:DRUG),(NYSE:LLY) EQNX::TICKER_END

Via FinancialNewsMedia

Crude Oil Moves Higher; UPS Cuts FY23 Guidance ↗

August 08, 2023

U.S. stocks traded lower toward the end of trading, with the Dow Jones falling over 200 points on Tuesday. The Dow traded down 0.64% to 35,246.87 while the NASDAQ fell 0.98% to 13,857.43. The S&P 500,...

Via Benzinga

Dow Drops 343 Points Amid Bank Sector Gloom ↗

August 08, 2023

Stocks are extending their morning losses, with the banking sector weighing on the market after Moody cut its credit rating on several U.S. banks.

Via Talk Markets

Why Energizer Holdings Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

August 08, 2023

Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 185.6% to $1.6593 after the company announced contract with NASA to demonstrate feasibility of power beaming in space using the company’s blue laser...

Via Benzinga

Bright Minds Biosciences Inc. (NASDAQ: DRUG) Leading the Way in Tuesday Trading Based on Percentage Gain

August 08, 2023

Via Investor Brand Network

Bright Mind Shares Surge 91% After Reporting Positive EEG Clinical Results Of Next-Gen Compound ↗

August 08, 2023

After Bright Minds Bioscience's (NASDAQ: DRUG) announcement that its quantitative EEG garnered positive results, the company stock shot up 91% Tuesday morning, spiking to $6.18 from Monday's close...

Via Benzinga

Dow Falls 1%; Eli Lilly Raises Annual Guidance ↗

August 08, 2023

U.S. stocks were lower midway through trading, with the Dow Jones falling over 1% on Tuesday. The Dow traded down 1.05% to 35,099.88 while the NASDAQ fell 1.47% to 13,788.21. The S&P 500, also fell,...

Via Benzinga

Nasdaq Down Over 100 Points; US Trade Deficit Shrinks In June ↗

August 08, 2023

U.S. stocks were lower this morning, with the Nasdaq Composite falling more than 100 points on Tuesday. Following the market opening Tuesday, the Dow traded down 0.82% to 35,182.19 while the NASDAQ...

Via Benzinga

Psyched: Portugal Decriminalizes Synthetic Drugs, Anorexia And Psilocybin, LSD Microdosing, California & More ↗

August 03, 2023

A Revolutionary Approach: Portugal Decriminalizes Synthetic Drugs Portugal’s Parliament recently decriminalized the use of synthetic drugs. The new law equates the legal treatment of these substances...

Via Benzinga

Small Pharma's Q1 2024: Revamping Strategy And Potential Fast-Tracked Clinical Trial ↗

July 28, 2023

UK’s short-acting psychedelics developer Small Pharma (OTCQB: DMTTF) published its financial results for the fiscal first quarter ended May 31, 2023:

Via Benzinga

Cybin, Bright Minds And PharmAla: A Short Recap On Progress Within Clinical Trials ↗

July 24, 2023

Cybin One Steps Away From Complete Dosing

Via Benzinga

Psyched: NDAA Amendments Blocked, National Practitioners Network, Marijuana In Jackie Kennedy's Garden And More ↗

July 19, 2023

GOP-Controlled House Committee Blocks All Cannabis & Psychedelics Amendments To Defense Bill: Now, No Floor Vote

Via Benzinga

Bright Minds Goes For 5:1 Shares Consolidation, Hopes To Regain NASDAQ Compliance ↗

July 11, 2023

Bright Minds Biosciences Inc. (NASDAQ: DRUG) is going for a consolidation of its common shares on a five-to-one basis, a plan approved by the company’s board of directors in June.

Via Benzinga

Psyched: LSD For Major Depression, Canada's Psilocybin Macrodose Trial, Treatments For Multiple Sclerosis And More ↗

April 24, 2023

LSD Trial Study Shows Potential For Major Depression Psychedelics biopharma company Mind Medicine Inc. (NASDAQ: MNMD) recently shared positive topline data from an advanced clinical trial of LSD as a...

Via Benzinga

Stress, Anxiety, PTSD: 2 NASDAQ-Listed Drug Developers Advance Psychedelic-Inspired Meds ↗

April 20, 2023

Psychedelics biotech Silo Pharma Inc. (NASDAQ: SILO) and Columbia University are developing a novel compound formulation as a prophylactic treatment for stress, anxiety and PTSD.

Via Benzinga

Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

April 19, 2023

Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

April 19, 2023

It's time for another dive into the biggest pre-market stock movers traders will want to know about on Wednesday morning!

Via InvestorPlace

EXCLUSIVE: Insider's Peek At Mammoth Of Psychedelics VCs, Palo Santo, Market Subverticals & Informal Guidance ↗

November 07, 2022

(Part four of a four-part series) See previous stories in this series:

Via Benzinga

Why Quoin Pharmaceuticals Shares Jumped By More Than 44%; Here Are 57 Biggest Movers From Yesterday ↗

October 19, 2022

Gainers COMSovereign Holding Corp. (NASDAQ: COMS) shares jumped 170.1% to close at $0.1194 on Tuesday after gaining 4% on Monday.

Via Benzinga

< Previous 1 2 3 4 5 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.